1.950SEK+8.82%Mkt Cap: 60.55M SEKP/E: —Last update: 2026-05-13
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testin…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-10.63
PEG—
P/B-4.00
P/S257.67
EV/EBITDA-1.02
EV/Revenue79.40
EPS (TTM)-1.30
EPS (Forward)-0.18
Cash Flow & Leverage
FCF Yield-18.62%
FCF Margin-4798.88%
Operating CF-16.77M SEK
CapEx (TTM)—
Net Debt/EBITDA-0.11
Net Debt2.08M SEK
Technical
SMA 501.972 (-1.1%)
SMA 2002.378 (-18.0%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)41.35K
Avg Vol (10d)60.98K
Technical Indicators
RSI (14)52.3
MACD-0.0367
MACD Signal-0.0390
MACD Hist.+0.0023
BB Upper2.010 SEK
BB Middle1.892 SEK
BB Lower1.773 SEK
BB Width12.54%
ATR (14)0.1552 SEK
Vol Ratio (20d)1.84x
52W Range
1.20516% of range5.740
52W High5.740 SEK
52W Low1.205 SEK
Profitability
Gross Margin-206.79%
EBITDA Margin0.00%
Profit Margin-6345.06%
Oper. Margin-27714.28%
ROE273.81%
ROA-213.43%
Revenue Growth-80.90%
Earnings Growth—
Balance Sheet
Debt/Equity-1.14
Current Ratio2.31
Quick Ratio1.57
Book Value/Sh-0.4790 SEK
Cash/Share0.7660 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2000
Split DateJul 30, 2024
Ownership
Shares Out.31.64M
Float8.66M
Insiders0.00%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap60.55M SEK
Enterprise Value18.66M SEK
Revenue (TTM)235.00K SEK
Gross Profit-670.00K SEK
Net Income (TTM)-20.56M SEK
Revenue/Share0.0190 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
Last Price1.950 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—